FDA Warning on Drugs for ADHD
The FDA is requiring new labeling changes for stimulant drugs used to treat ADHD. Most, it appears, are variations on methylphenidate (Ritalin, Concerta, etc.). The drugs have produced side-effects including, according to the FDA, events such as visual hallucinations, suicidal ideation, psychotic behavior, as well as aggression or violent behavior. The FDA is seeking the panel’s advice on what information it should provide to the public about the ADHD drugs that are widely used in children while it’s collecting information on the number of types of psychiatric events possibly associated with ADHD drugs along with possible cardiovascular risks.